Steinherz, Laurel J

Publications

Sort by

Co-Author Network

selected publications

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group. Pediatric blood & cancer. 2015 Academic Article GET IT
Times cited: 65
Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma. 2015 GET IT
Times cited: 9
Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia. Pediatric blood & cancer. 2013 Academic Article GET IT
Times cited: 25
Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia. Pediatric blood & cancer. 2010 Academic Article GET IT
Times cited: 16
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 70
Early breast cancer therapy and cardiovascular injury. Journal of the American College of Cardiology. 2008 Letter GET IT
Times cited: 3
Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia. 2007 GET IT
Times cited: 7
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Academic Article GET IT
Times cited: 221
Using health-related quality of life measures to predict cardiac function in survivors exposed to anthracyclines. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 17
Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 233
Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers. Medical and pediatric oncology. 2003 Academic Article GET IT
Times cited: 34
Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 46
Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy. Pediatric hematology and oncology. 2002 Academic Article GET IT
Times cited: 17
Pythium insidiosum pleuropericarditis complicating pneumonia in a child with leukemia. 2002 GET IT
Times cited: 20
Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia. 2002 Academic Article GET IT
Times cited: 50
Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors. American heart journal. 2001 Academic Article GET IT
Times cited: 33
A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors. Cancer. 1998 Academic Article GET IT
Times cited: 20
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group. Medical and pediatric oncology. 1996 Academic Article GET IT
Times cited: 33
Cardiac tamponade in the pediatric oncology population: treatment by percutaneous catheter drainage. Journal of pediatric surgery. 1996 Academic Article GET IT
Times cited: 23
Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Medical and pediatric oncology. 1995 Academic Article GET IT
Times cited: 193
Guidelines for monitoring of anthracycline cardiomyopathy: a rebuttal. Pediatrics. 1994 Letter GET IT
Times cited: 10
A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. Journal of pediatric surgery. 1994 Academic Article GET IT
Times cited: 40
Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol. Cancer. 1993 Academic Article GET IT
Times cited: 93
Sick sinus syndrome in a teenager treated with idarubicin. Journal of cardiothoracic and vascular anesthesia. 1993 Letter GET IT
Times cited: 5
Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. 1992 GET IT
Times cited: 341
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study Group. Medical and pediatric oncology. 1992 Academic Article GET IT
Times cited: 12
Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991 Academic Article GET IT
Times cited: 906
Delayed cardiac toxicity from anthracycline therapy. Pediatrician. 1991 Academic Article GET IT
Times cited: 53
Transfusion-associated acute Chagas disease acquired in the United States. 1989 GET IT
Times cited: 181
Phase I trial of homoharringtonine in children with refractory leukemia. Cancer treatment reports. 1987 Academic Article GET IT
Times cited: 19
Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer. Cancer research. 1987 Academic Article GET IT
Times cited: 38
Isolated cardiac metastatic recurrence of epithelioid sarcoma after two and a half disease-free years. 1987 GET IT
Times cited: 3
Cardiac involvement in congenital acquired immunodeficiency syndrome. 1986 GET IT
Times cited: 42
Transient, marked, unexplained elevation of serum alkaline phosphatase. 1984 GET IT
Times cited: 22
Lymphomatous leptomeningitis as a presenting syndrome of Hodgkin's disease. 1983 GET IT
Times cited: 15
Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma. Cancer research. 1982 Academic Article GET IT
Times cited: 15
Cardiac abnormalities after AMSA administration. Cancer treatment reports. 1982 Academic Article GET IT
Times cited: 28
Cardiac changes with cyclophosphamide. Medical and pediatric oncology. 1981 Academic Article GET IT
Times cited: 81
Phase I trial of rubidazone (NSC 164011) in children with cancer. Medical and pediatric oncology. 1981 Academic Article GET IT
Times cited: 5
Use of hydralazine for intractable cardiac failure in childhood. 1980 GET IT
Times cited: 13
Membranous subaortic stenosis and patent ductus arteriosus. Chest. 1977 Academic Article GET IT
Times cited: 11
Recent advances in the diagnosis and treatment of congenital heart disease. Southern medical journal. 1977 Review GET IT
Times cited: 1

more ...

less ...

Background

education and training

M.D., Albert Einstein College of Medicine of Yeshiva University 1970
A.B., University of Rochester 1967

Contact

full name

Laurel J Steinherz

VIVO Weill Cornell Medical College

Laurel J Steinherz Professor of Clinical Pediatrics

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name